Serum HBsAg and ddPCR HBV-DNA as predictive parameters of HBsAg loss after nucleo (s)tide analogue (NA) treatment discontinuation in non-cirrhotic patients with chronic hepatitis B
Digestive and Liver Disease(2022)
Abstract
Introduction: Stopping nucleo(s)tide analogue (NA) treatment in selected non-cirrhotic Chronic Hepatitis B (CHB) often leads to virus-induced flares, which may result to life-threatening liver failure.
MoreTranslated text
Key words
serum hbsag,hepatitis,hbsag loss,hbv-dna,non-cirrhotic
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined